The international Society of Chemical Manufacturers and Affiliates (SOCMA) has outlined its legislative priorities for 2010 for the second session of 111th Congress, plans for its national grassroots program — SOCMA Connect — and efforts to launch a voter-registration drive ahead of the November mid-term elections.
The international Society of Chemical Manufacturers and Affiliates (SOCMA) has outlined its legislative priorities for 2010 for the second session of the 111th Congress, plans for its national program SOCMA Conect and efforts to launch a voter-registration drive before the November mid-term elections.
"Our priorities this year are similar to those in 2009, but our message will more forcefully communicate how overreaching legislation will negatively impact specialty chemical manufacturers, particularly small and mid-sized producers," Bill Allmond, SOCMA's Vice President of government relations and ChemStewards, an environmental, health, and safety program, said in a SOCMA press release. "With unemployment still at 10%, Congress should be doing all it can to take concerns about new regulatory burdens more seriously."
SOCMA's key legislative priorities revolve around: chemical-site security, reform of the Toxic Substances Control Act (TSCA), climate change, food and drug safety, R&D tax credits and trade.
SOCMA says it "will continue to support permanent risk-based regulations that comprehensively address security at chemical facilities." In November 2009, the US House of Representatives passed legislation that included chemical-site security measures with IST provisions. The IST provisions add a requirement to existing industry security standards to mandate process or chemical substitution of certain chemicals as directed by the US Department of Homeland Security. IST is a conceptual framework that covers chemical-processing procedures, equipment, protection and, when feasible, the use of safer substances.
Although SOCMA favors chemical-security measures, the group opposes mandating IST. "SOCMA members sent over 200 letters to members of Congress last year voicing their opposition to mandating IST in this bill," said Allmond. "Our grassroots efforts are now focused on the Senate, which is expected to give greater consideration to the harmful effects IST implementation would have on batch chemical manufacturers."
SOCMA is also participating in the chemicals-management policy debate. TSCA provides the US Environmental Protection Agency with authority to require reporting, recordkeeping, testing, and restrictions relating to chemical substances or mixtures. "Any reform of TSCA should leverage regulatory efforts that have demonstrated success, while maintaining a fundamentally risk-based framework that prioritize chemicals for further review," said Allmond.
The association says it will continue to monitor climate legislation and regulatory activity, including the Clean Energy Jobs and American Power Act (S. 1733), which awaits action by the Senate. SOCMA thinks that a cap-and-trade bill will not likely pass the Senate this year, but that it expects that "a major climate-change/clean-energy bill will remain a top Democratic Congressional priority over the next two years."
SOCMA says it will continue to address the risks associated with importation of APIs from emerging markets and overall food and drug safety. The key piece of legislation that it is monitoring is the Food Safety Enhancement Act of 2009 (HR 2749) that passed the House and was referred to the Senate Health, Education, Labor, and Pensions Committee for consideration.
The association is also seeking to permanently extend R&D tax credits. "Our industry does its part by spending large amounts each year to design new products that support our economy and daily living," said Allmond. "Government incentives such as the R&D tax credit go a long way toward spurring innovation of these products and protecting and growing jobs."
SOCMA says it supports pending free-trade agreements (FTAs) with South Korea, Panama, and Columbia and would welcome the passage of a US-Korea FTA in 2010. SOCMA says it plans to follow closely the administration’s efforts to move forward with a trans-Pacific Partnership. "This administration has emphasized that boosting exports is a part of its economic agenda, and we will be supporting efforts in Congress to ensure that export-oriented growth that benefits our membership is a priority," Allmond said in the release.
The association also is launching new services under a program called SOCMA CONNECT to assist members in their Congressional advocacy efforts. These web-based tools will allow SOCMA members to research election dates, races, and issue information. SOCMA CONNECT will also initiate voter-registration drives and provide email updates on races and candidates.
See related stories
House Committee Passes IST Requirements in Chemical Facility Security Bill (ePT)
SOCMA updates advocacy against IST provisions (ePT)
Why is the PDA Pharmaceutical Microbiology Conference the Hottest Ticket in the Industry?
October 10th 2024Get a glimpse of the power and popularity behind the PDA Pharmaceutical Microbiology Conference from two planning committee members, Julia Marre, PhD (Associate Director, Scientific and Regulatory Affairs at Pocket Naloxone Corp) and Dawn Watson (Executive Director, Global Micro Quality and Sterility Assurance at Merck). This candid conversation reveals why this industry event is so influential…and always sold out! The speakers discuss what makes the PDA Pharmaceutical Microbiology Conference so vital to industry professionals, as well as how to become a part of this dynamic professional community.
Navigating Annex 1 for Early Phase Sterile Fill Finish in Clinical Supplies
November 21st 2024Stay compliant with Annex 1 for early phase sterile fill finish processes. Discover how to implement robust contamination control strategies, integrate isolator technology, and conduct integrity testing to meet stringent European Union standards. The guide provides a comprehensive look at key elements such as PUPSIT, critical zone controls, and monitoring and training for aseptic processes.
Your Ultimate Guide for CMC Testing Support for Gene and Cell Therapy
November 21st 2024Explore the complexities of gene and cell therapy development with our comprehensive guide to Chemistry, Manufacturing, and Controls (CMC) testing. Learn how our expertise ensures the safety, potency, and quality of advanced therapies, supporting your journey from product development through regulatory approval.